An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
Rachael Natrajan(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Britta Weigelt(Memorial Sloan Kettering Cancer Center), Anita Grigoriadis(London Cancer), Alan Ashworth(University of California, San Francisco), David S.P. Tan(National University of Singapore), Alan Mackay(Institute of Cancer Research), Christopher J. Lord(Institute of Cancer Research), José Palacios(Universidad de Alcalá), Felipe C. Geyer(Institute of Cancer Research), Socorro Marıá Rodríguez-Pinilla(Centro Nacional de Investigaciones Científicas), Radost Vatcheva(Institute of Cancer Research), Chris Jones(North Carolina State University)
Cited by 153
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
|New England Journal of Medicine|2012|1k